1 |
9 Meters Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
2 |
Acacia Pharma Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
3 |
Acerus Pharmaceuticals Corporation (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
4 |
Active Fine Chemicals Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
5 |
Adamas Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
6 |
Advanz Pharma Corp Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
7 |
Aeon Biopharma Sub Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
8 |
Aerie Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
9 |
Aktsnrny Krgnsky bshchstv Mdtsnskkh (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
10 |
Albireo Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
11 |
Alexion Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
12 |
American Bio Medica Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
13 |
Arena Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
14 |
Aveo Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
15 |
BELLUS Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
16 |
BioDelivery Sciences International, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
17 |
Biofermin Pharmaceutical Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
18 |
Boehringer Ingelheim GmbH (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
19 |
Calithera Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
20 |
Cann Global Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
21 |
Capstone Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
22 |
Chembio Diagnostics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
23 |
Chemo Pharma Laboratories Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
24 |
ChemoCentryx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
25 |
Chiasma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
26 |
Clarus Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
27 |
Coeptis Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
28 |
Colabs Int'l Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
29 |
Constellation Pharmaceuticals Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
30 |
CTI BioPharma Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
31 |
Dal'khimfarm OAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
32 |
Diogene Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
33 |
Diurnal Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
34 |
Elicio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
35 |
Entasis Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
36 |
Eom Pharmaceutical Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
37 |
Farmak AT (Ukraine) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
38 |
Flexion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
39 |
Forward Pharma A/S (ADR) (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
40 |
Fresenius Kabi Oncology Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
41 |
FUREN Group Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
42 |
Gaia Grow Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
43 |
Gelteq Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
44 |
Generex Biotechnology Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
45 |
Genocea Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
46 |
Green Cross Cell Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
47 |
INDVR Brands Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
48 |
Inner Spirit Holdings Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
49 |
Jadran Galenski Laboratorij dd (Croatia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
50 |
JFL Life Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
51 |
Jilin Zixin Pharmaceutical Ind. Co., Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
52 |
Jubilant Pharma Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
53 |
Kadmon Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
54 |
Kappac Pharma Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
55 |
Karo Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
56 |
Kolinpharma SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
57 |
Kyivmedpreparat AT (Ukraine) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
58 |
Labomar SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
59 |
LFB S.A. (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2016 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
60 |
Macleods Pharmaceuticals Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
61 |
Med X Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
62 |
Melt Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
63 |
Mercury Pharma Group Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
64 |
Mindset Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
65 |
MusclePharm Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
66 |
Nichi-iko Pharmaceutical Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
67 |
North Sur Resources Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
68 |
Nugenerex Immuno-Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
4/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
69 |
Nuvo Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
70 |
Odonate Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
71 |
Olainfarm AS (Latvia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
72 |
Parenteral Drugs (India) Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
73 |
Pharmacare PLC (Palestinian territories) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
74 |
Pierrel S.p.A. (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
75 |
Polydex Pharmaceuticals Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
76 |
Pymepharco JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
77 |
Q BioMed Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
78 |
Quotient Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
79 |
RegeneRx Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
80 |
Reunion Neuroscience, Inc. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
81 |
Sangui Biotech International Inc (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
82 |
Satsuma Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
83 |
Selectimmune Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
84 |
Sharon Bio-Medicine Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
85 |
Sierra Oncology Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
86 |
Sio Gene Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
87 |
Societe Adwya SA (Tunisia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
88 |
Spectrum Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
89 |
Squarex Pharmaceutical Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
90 |
Ste Tunisienne Des Industries Phaqu SA (Tunisia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
91 |
Strongbridge Biopharma plc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
92 |
Sunwin Stevia International Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
93 |
Syncom Healthcare Limited (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
94 |
Vifor Pharma AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
95 |
Vilin Bio Med Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
96 |
Vitalibis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
97 |
Vividion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
98 |
Wockhardt Bio AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
99 |
Wyeth Pakistan Ltd (Pakistan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
100 |
Zogenix, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |